ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Year-over-year total asset growth rate
3Y CAGR
-6.9%/yr
vs +8.0%/yr prior
Acceleration
-15.0pp
Decelerating
Percentile
P59
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.29% |
| Q3 2025 | 4.85% |
| Q2 2025 | 3.91% |
| Q1 2025 | 0.68% |
| Q4 2024 | -0.29% |
| Q3 2024 | 39.82% |
| Q2 2024 | 0.68% |
| Q1 2024 | 1.12% |
| Q4 2023 | 1.63% |
| Q3 2023 | 3.56% |
| Q2 2023 | 12.30% |
| Q1 2023 | 0.68% |
| Q4 2022 | 2.84% |
| Q3 2022 | -1.63% |
| Q2 2022 | 0.87% |
| Q1 2022 | -3.47% |
| Q4 2021 | 64.01% |
| Q3 2021 | -2.02% |
| Q2 2021 | 3.52% |
| Q1 2021 | 0.58% |
| Q4 2020 | -0.30% |
| Q3 2020 | -0.60% |
| Q2 2020 | -3.49% |
| Q1 2020 | 5.57% |
| Q4 2019 | 0.00% |
| Q3 2019 | 2.21% |
| Q2 2019 | 2.88% |
| Q1 2019 | 0.88% |
| Q4 2018 | -2.01% |
| Q3 2018 | 3.60% |
| Q2 2018 | 1.47% |
| Q1 2018 | 1.43% |
| Q4 2017 | 11.25% |
| Q3 2017 | 3.13% |
| Q2 2017 | 0.58% |
| Q1 2017 | 10.62% |
| Q4 2016 | 1.09% |
| Q3 2016 | 3.69% |
| Q2 2016 | 5.63% |
| Q1 2016 | 2.22% |